RK-9123016
CAS No. 955900-27-3
RK-9123016 ( RK 9123016; RK9123016 )
Catalog No. M27923 CAS No. 955900-27-3
RK-9123016 is a SIRT2 inhibitor. RK-9123016 increases the acetylation level of eukaryotic translation initiation factor 5A (eIF5A), a physiological substrate of SIRT2, and reduces cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | Get Quote |
|
10MG | 68 | Get Quote |
|
25MG | 115 | Get Quote |
|
50MG | 173 | Get Quote |
|
100MG | 258 | Get Quote |
|
200MG | 388 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRK-9123016
-
NoteResearch use only, not for human use.
-
Brief DescriptionRK-9123016 is a SIRT2 inhibitor. RK-9123016 increases the acetylation level of eukaryotic translation initiation factor 5A (eIF5A), a physiological substrate of SIRT2, and reduces cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression.
-
DescriptionRK-9123016 is a SIRT2 inhibitor. RK-9123016 increases the acetylation level of eukaryotic translation initiation factor 5A (eIF5A), a physiological substrate of SIRT2, and reduces cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression.(In Vitro):RK-9123016 inhibited the enzymatic activity of SIRT2 with an IC50 value of 0.18 μM but not other human sirtuin members including SIRT1 and SIRT3 at 100 μM in vitro electrophoretic mobility shift assay. RK-9123016 inhibited the SIRT2 activity in MCF-7 cells by concentration dependent manner (0-30 μM).
-
SynonymsRK 9123016; RK9123016
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorFatty Acid Synthase (FASN)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number955900-27-3
-
Formula Weight374.4
-
Molecular FormulaC16H18N6O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(\C=N\NC(=S)NCC=C)cc1Cn1cc(cn1)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Giorgia Zadra, et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):631-640.
molnova catalog
related products
-
Octyl gallate
Octyl Gallate is an antioxidant approved by the US Food and Drug Administration (FDA) as a food additive. Octyl Gallate has antimetastatic activity.
-
JGB1741
JGB1741 is a potent and selective inhibitor of SIRT1 with an IC50 of 15 μM. JGB1741 modulates Bax/Bcl2 ratio, cytochrome c release and PARP cleavage and increases the acetylated p53 levels leading to p53-mediated apoptosis. JGB1741 can be used in studies about breast cancer.
-
Tenovin-6 Hydrochlor...
Tenovin-6 Hydrochloride is an SIRT1, SIRT2 and HDAC8 inhibitor(IC50s of 21 μM, 10 μM, and 67 μM for SirT1, SirT2, and SirT3, respectively), and is also a potent p53 activator.